Wellington Shields & Co’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$391K Hold
2,694
0.09% 181
2026
Q1
$286K Hold
2,694
0.07% 205
2025
Q4
$286K Sell
2,694
-66
-2% -$6.66K 0.07% 200
2025
Q3
$259K Hold
2,760
0.07% 203
2025
Q2
$239K Hold
2,760
0.07% 200
2025
Q1
$213K Hold
2,760
0.07% 205
2024
Q4
$267K Hold
2,760
0.08% 178
2024
Q3
$262K Sell
2,760
-100
-3% -$8.73K 0.08% 193
2024
Q2
$239K Hold
2,860
0.08% 188
2024
Q1
$246K Hold
2,860
0.08% 190
2023
Q4
$236K Sell
2,860
-333
-10% -$24.4K 0.09% 189
2023
Q3
$230K Sell
3,193
-100
-3% -$7.59K 0.06% 186
2023
Q2
$250K Sell
3,293
-200
-6% -$13.4K 0.06% 182
2023
Q1
$220K Buy
+3,493
New +$205K 0.05% 202
2022
Q2
Sell
-3,593
Closed -$206K 285
2022
Q1
$206K Buy
+3,593
New +$185K 0.07% 205
2021
Q3
Sell
-4,224
Closed -$248K 214
2021
Q2
$248K Hold
4,224
0.08% 179
2021
Q1
$275K Sell
4,224
-100
-2% -$6.14K 0.1% 157
2020
Q4
$238K Sell
4,324
-333
-7% -$17K 0.09% 156
2020
Q3
$205K Buy
+4,657
New +$205K 0.09% 161
2020
Q1
Sell
-4,657
Closed -$207K 157
2019
Q4
$207K Buy
+4,657
New +$179K 0.09% 161

Other funds holding ACA

Wellington Shields & Co's ACA Position: Q2 2026 in Review

Wellington Shields & Co held its Arcosa (ACA) position steady in Q2 2026 at 2,694 shares worth $391K. The position accounts for 0.09% of the portfolio, ranked #181.

Wellington Shields & Co first reported a position in ACA in Q4 2019 and has held it in 20 quarters since. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Wellington Shields & Co held 2,694 shares of Arcosa worth $391K as of Q2 2026.
  • Wellington Shields & Co left its Arcosa share count unchanged in Q2 2026.
  • Arcosa made up 0.09% of Wellington Shields & Co's portfolio in Q2 2026, its #181 holding.
  • Wellington Shields & Co first reported a position in Arcosa in Q4 2019 and has held it in 20 quarters since.
  • 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.